Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Other(3)

Detailed Status

unknown3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

unknown375%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

Clinical and Imaging Biomarkers Associated With Plasma ad Cellular Determinants of Cardiovascular Disease at the Time of COVID 19

NCT05745753
unknown

Cardiovascular Events for a Long Time End of COVID 19 Infection

NCT05729152
unknownnot_applicable

Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells

NCT01725438
completed

Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia

NCT00913042

Clinical Trials (4)

Showing 4 of 4 trials
NCT05745753Not Applicable

Clinical and Imaging Biomarkers Associated With Plasma ad Cellular Determinants of Cardiovascular Disease at the Time of COVID 19

Unknown
NCT05729152

Cardiovascular Events for a Long Time End of COVID 19 Infection

Unknown
NCT01725438Not Applicable

Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells

Unknown
NCT00913042

Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4